Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Cureus ; 16(9): e68725, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39371816

ABSTRACT

Dental implants are fixtures that replace a natural tooth that has been missing. The outcome depends on the safety and longevity of the bone-implant relationship. The process of direct and strong anchoring of an implant due to the surrounding bone tissue growing around it is called osseointegration. The establishment of an osseointegrated contact depends on a variety of systemic and local variables and diagnostic methods. Resonance frequency analysis is one of the methods used to analyze implant stability. The surface topography, mainly surface texture and roughness, also helps in promoting a favorable interaction between the implant and biological tissues. This case report aimed to indicate the importance of implant surfaces showing primary and secondary stability and implant stability quotient (ISQ) values that can be analyzed by resonance frequency analysis (RFA) using the Osstell implant device, which can be a useful tool used to determine the risk of failure.

2.
Cureus ; 16(9): e68719, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39371876

ABSTRACT

Periodontitis, a bacterial infection leading to the destruction of tooth-supporting tissues, is primarily driven by elevated levels of subgingival microorganisms. Effective periodontal therapy aims to eliminate or reduce these pathogens to halt disease progression, prevent recurrence, and regenerate lost tissues. This case report evaluates the effectiveness of non-surgical therapies, specifically tetracycline fibers and photobiomodulation therapy (PBMT), as adjuncts to scaling and root planing (SRP) in the treatment of periodontal disease using a split-mouth design. Mechanical SRP alone may not fully remove pathogens from deep periodontal pockets, potentially leading to disease recurrence. To address this, various other techniques have been explored, including the use of tetracycline fibers and PBMT. Local delivery methods aim to minimize systemic side effects while maintaining high antimicrobial concentrations in the gingival crevicular fluid, whereas PBMT, known for its anti-inflammatory and regenerative properties, involves exposing tissues to low-intensity light with wavelengths from red to near-infrared. This therapy activates cellular functions and mitochondrial processes, resulting in increased adenosine triphosphate (ATP) production, nitric oxide levels, and overall tissue healing. Tetracycline fibers have been highlighted for their effectiveness in periodontal therapy due to their localized antimicrobial action. The integration of tetracycline fibers and PBMT with SRP presents a promising non-surgical approach to enhance the management of periodontal disease. The case report aims to provide insights into the efficacy of these adjunctive therapies in improving clinical outcomes for patients with periodontitis.

3.
Bioinformation ; 20(5): 579-582, 2024.
Article in English | MEDLINE | ID: mdl-39132240

ABSTRACT

Teeth that are lost can be replaced with dental implants. A sufficient width of bone surrounding the implant is beneficial to its success. Therefore, it is of interest to examine alterations in width of alveolar bone surrounding dental implants at natural and rebuilt bone locations [alveolar ridge preservation (ARP) /Guided Bone Regeneration (GBR)] using CTBT. A CBCT examination of the implant recipient site was performed on sixty patients (both male and female), who had undergone dental implants. All conventional surgical procedures were followed for inserting dental implants. All participants had their horizontal alveolar bone widths around implants assessed at 3 positions: subcrestal width 1 mm (CW1 (crestal level-CW1), subcrestal width 4 mm (CW4), and subcrestal width 7 mm (CW7). There were 32 male patients and 28 female patients out of 60 totals. The mean bone width was 7.02 mm at CW1 prior to surgery and 6.91 mm afterward; it was 8.52 mm at CW4 and 8.13 mm afterward; and it was 10.21 mm at CW7 prior to surgery and 10.08 mm afterward. There was a substantial difference (P<0.05). At CW1, the bone width was 0.38 mm at local bone and -0.02 mm at ARP/GBR; at CW4, the bone width was 0.46 mm at local bone and 0.23 mm at ARP/GBR; and at CW7, the bone width was 0.22 mm at local bone and 0.02 mm at ARP/GBR. There was no discernible difference (P>0.05). Resorption of the alveolar bone width was only noticeable at the middle third of the sites. Long-term alterations in the alveolar bone width surrounding dental implants at local and rebuilt bone sites can be observed using CBCT images.

4.
J Surg Case Rep ; 2024(5): rjae304, 2024 May.
Article in English | MEDLINE | ID: mdl-38812578

ABSTRACT

Gingival enlargement is a side effect of several different medication, including immunosuppressants, anticonvulsants, and calcium channel blockers. It is an inflammatory response that starts when plaque and calculus build up on the tooth surface. The most prevalent long-term neurological condition affecting people is epilepsy. In affluent nations, the prevalence of epilepsy is ~ 1%, whereas in less developed countries, it may >2%. The preferred medication for the condition, phenytoin, has major side effects include gingival enlargement. In addition to being visually disfiguring, this enlargement frequently affects speech, chewing and eating. Furthermore, those with poor dental hygiene, causes disabilities with motor coordination and muscular limitations leading to mental disability and physical impairments are more prone to periodontal disease. This article enlightened the mechanism of drug induced gingival enlargement clinically, microbiologically, and surgically.

5.
J Pharm Bioallied Sci ; 16(Suppl 1): S140-S142, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38595363

ABSTRACT

Objectives: To assess the role of bisphosphonate on osteotomy site and implant surface. Materials and Methods: Twenty patients with adequate width and height of edentulous space and a single missing posterior tooth between the ages of 25 and 55 were incorporated in this research. Ten participants received implant therapy alone; the other ten patients received implant therapy and bisphosphonate application to osteotomy site and the implant surface. Result: Changes in the crestal bone level were seen in both the study and control groups. At 1 year, crestal bone loss was less in the bisphosphonate-treated group than in the control group. Conclusion: The quantity of crestal bone loss was reduced when bisphosphonate (sodium alendronate) was applied locally near the implant and osteotomy site.

SELECTION OF CITATIONS
SEARCH DETAIL